RE: The New INT Agreement.......DDP-IV Inhibitors
Have you noticed?.
The way the G1+DDP-IV Inhibitors are flying through Pe-Clinicals so fast it leads me to believe that they will be a very big part of the New INT Agreement that Novo and Transition are Hammering Out. I'd expect Stringent Performance Guarantees will be required from Novo this time around!
Leer Target for ---TTHI ---us$21---OutPerform
GLA